• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Milestone Pharmaceuticals Inc. - Common Shares (NQ:MIST)

    1.585 -0.135 (-7.85%)
    Streaming Delayed Price Updated: 9:47 AM EDT, May 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Milestone Pharmaceuticals Inc. - Common Shares

    < Previous 1 2 3 Next >
    News headline image
    Why Milestone Pharmaceuticals Stock Wilted on Wednesday ↗
    The biotech fell well short of analyst projections in the first quarter. 
    Via The Motley Fool
    News headline image
    Milestone Pharmaceuticals Q1 Earnings Call Highlights ↗
    Milestone Pharmaceuticals (NASDAQ:MIST) said its first quarter of 2026 marked the beginning of commercial sales for CARDEMYST, its newly approved treatment for acute episodes of paroxysmal... 
    Via MarketBeat
    Topics Earnings
    News headline image
    Milestone Reports Q1 Results, Highlights Initial CARDAMYST Sales ↗
    Milestone Pharmaceuticals Inc. (NASDAQ: MIST) reported first-quarter earnings on Wednesday before the market opened. 
    Via Benzinga
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    Milestone Pharmaceuticals (NASDAQ:MIST) Reports First Revenue with Q4 2025 Earnings, Beats Estimates ↗
    Via Chartmill
    Topics Earnings
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    MIST Stock Soars Pre-Market After FDA Approves First Commercial Product – Retail Remains Bullish, Dismisses ‘Sell The News’ Concerns ↗
    Milestone stated in its announcement that the approval of Cardamyst opens up an addressable market of more than two million Americans who suffer from PSVT. 
    Via Stocktwits
    News headline image
    Monday's pre-market session: top gainers and losers ↗
    As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
    Via Chartmill
    News headline image
    Let's take a look at the stocks that are in motion in today's session. ↗
    Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
    Via Chartmill
    News headline image
    Milestone Pharmaceuticals (NASDAQ:MIST) Posts Narrower-Than-Expected Q3 Loss as Key FDA Decision Looms ↗
    Milestone Pharmaceuticals beat Q3 earnings estimates, with a narrower loss. The stock rose as investors await the December 2025 FDA decision for its lead drug, CARDAMYST™. 
    Via Chartmill
    News headline image
    Let's take a look at the stocks that are in motion in today's session. ↗
    Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
    Via Chartmill
    News headline image
    Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Which stocks are moving on Friday? ↗
    Stay up-to-date with the latest market trends in the middle of the day on Friday. Explore the top gainers and losers during today's session in our detailed report. 
    Via Chartmill
    News headline image
    Why Is Milestone Pharmaceuticals Stock Plunging On Friday? ↗
    FDA accepts Milestone's response on Cardamyst nasal spray, sets new PDUFA date; company raises $52.5 million to support potential PSVT treatment launch. 
    Via Benzinga
    News headline image
    Dow Dips Over 200 Points; Levi Strauss Posts Upbeat Earnings ↗
     
    Via Benzinga
    Topics Stocks
    News headline image
    There are notable gap-ups and gap-downs in today's session. ↗
    Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
    Via Chartmill
    News headline image
    Wondering what's happening in today's pre-market session? ↗
    The US market session of Friday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Top movers analysis one hour before the close of the markets on 2025-03-28: top gainers and losers in today's session. ↗
    Looking for insights into the US markets one hour before the close of the markets on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
    Via Chartmill
    News headline image
    Top movers in Friday's session ↗
    Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
    Via Chartmill
    News headline image
    Milestone Pharmaceuticals Stock Plunges 60% After FDA Declines To Approve Its Cardamyst Nasal Spray – But Retail’s Positive ↗
    The FDA said an inspection is required at a facility where the company performed release testing for the product to ensure it complies with Current Good Manufacturing Practices. 
    Via Stocktwits
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
     
    Via Benzinga
    News headline image
    Traders are paying attention to the gapping stocks in Friday's session. ↗
    Let's have a look at what is happening on the US markets on Friday. Below you can find the gap up and gap down stocks in today's session. 
    Via Chartmill
    News headline image
    Dow Tumbles Over 500 Points; Abacus Global Management Shares Spike Higher ↗
     
    Via Benzinga
    Topics Stocks
    News headline image
    Top movers in Friday's pre-market session ↗
    The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
    Via Chartmill
    News headline image
    Why Is Milestone Pharmaceuticals Stock Plunging Today? ↗
    Milestone Pharmaceuticals' stock drops over 61% after receiving a Complete Response Letter from the FDA for its CARDAMYST NDA. 
    Via Benzinga
    News headline image
    Nasdaq Down 100 Points; Federal Reserve's Favorite Inflation Gauge Increases More Than Expected ↗
     
    Via Benzinga
    Topics Economy
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    MIST Stock Earnings: Milestone Pharmaceuticals Beats EPS for Q2 2024 ↗
    MIST stock results show that Milestone Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.